<DOC>
	<DOC>NCT00551811</DOC>
	<brief_summary>A study to evaluate the effect of SB-656933-AAA on the body after a single dose in subjects who have been challenged with ozone.</brief_summary>
	<brief_title>Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone.</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Healthy subjects between 1850 years. Females should be of nonchild bearing potential. Nonsmoking for at least 12 months. Normal lung function. Subjects should be able to produce acceptable sputum samples. Any serious medical condition. Hepatitis B or C and/or HIV positive. Currently on regular medication except paracetamol. Body Mass Index &lt;20 or &gt;30.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>SB-656933-AAA,</keyword>
	<keyword>single dose,</keyword>
	<keyword>ozone challenge</keyword>
</DOC>